Open AccessLIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?
Author(s) -
Su Metcalfe
Publication year - 2020
Publication title -
future virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.462
H-Index - 34
eISSN - 1746-0808
pISSN - 1746-0794
DOI - 10.2217/fvl-2020-0340
Subject(s) - covid-19 , pandemic , niche , lung , virology , stem cell , medicine , stem cell niche , biology , progenitor cell , microbiology and biotechnology , outbreak , infectious disease (medical specialty) , disease , ecology
Tweetable abstract What tips the SARS/COVID-19 balance into severe pneumonia, rather than recovery? Is it insufficient LIF – the lung’s own protective growth factor at the blood–air barrier?